CA2433308A1 - Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 - Google Patents

Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 Download PDF

Info

Publication number
CA2433308A1
CA2433308A1 CA002433308A CA2433308A CA2433308A1 CA 2433308 A1 CA2433308 A1 CA 2433308A1 CA 002433308 A CA002433308 A CA 002433308A CA 2433308 A CA2433308 A CA 2433308A CA 2433308 A1 CA2433308 A1 CA 2433308A1
Authority
CA
Canada
Prior art keywords
polypeptide
staau
seq
amino acid
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002433308A
Other languages
English (en)
French (fr)
Inventor
Michael DuBow
Jerry Pelletier
Philippe Gros
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Targanta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Targanta Therapeutics Inc filed Critical Targanta Therapeutics Inc
Publication of CA2433308A1 publication Critical patent/CA2433308A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002433308A 2000-12-20 2001-12-19 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 Abandoned CA2433308A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25648900P 2000-12-20 2000-12-20
US60/256,489 2000-12-20
PCT/CA2001/001847 WO2002050106A2 (en) 2000-12-20 2001-12-19 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4

Publications (1)

Publication Number Publication Date
CA2433308A1 true CA2433308A1 (en) 2002-06-27

Family

ID=22972412

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002433308A Abandoned CA2433308A1 (en) 2000-12-20 2001-12-19 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4

Country Status (5)

Country Link
EP (1) EP1345960A2 (https=)
JP (1) JP2004532612A (https=)
AU (2) AU2469202A (https=)
CA (1) CA2433308A1 (https=)
WO (1) WO2002050106A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111798712B (zh) * 2020-07-15 2021-10-29 周晓庆 噬菌体侵染细菌3d智能模拟方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU774841B2 (en) * 1998-12-03 2004-07-08 Targanta Therapeutics Inc. Development of novel anti-microbial agents based on bacteriophage genomics

Also Published As

Publication number Publication date
JP2004532612A (ja) 2004-10-28
WO2002050106A3 (en) 2002-12-12
EP1345960A2 (en) 2003-09-24
AU2002224692B2 (en) 2007-05-24
WO2002050106A2 (en) 2002-06-27
AU2469202A (en) 2002-07-01

Similar Documents

Publication Publication Date Title
US6660520B2 (en) Nrde
EP0899334A2 (en) FtsZ polypeptides from Streptococcus pneumoniae
US7326541B2 (en) Fragments and variants of Staphylococcus aureus DNAG primase, and uses thereof
AU2002224692B2 (en) Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein STAAU_R4
US6228584B1 (en) DexB
AU2002220422B2 (en) S.aureus protein STAAU R2, gene encoding it and uses thereof
US7101969B1 (en) Compositions and methods involving an essential Staphylococcus aureus gene and its encoded protein
US6361965B1 (en) YfiI pseudouridine synthase
US6277595B1 (en) FabZ
US6331411B1 (en) TopA
AU2002220422A1 (en) S.aureus protein STAAU R2, gene encoding it and uses thereof
US20040137516A1 (en) DNA sequences from staphylococcus aureus bacteriophage 44AHJD that encode anti-microbial polypeptides
US6194170B1 (en) MurF of Streptococcus pneumoniae
US6204014B1 (en) DnaB
AU3266201A (en) Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein
US6222014B1 (en) NrdE of staphylococcus aureus
US6261802B1 (en) Ups (ugc)
JPH11137248A (ja) ＭｕｒＡ
JPH11253176A (ja) ＭｕｒＦ
EP0892063A2 (en) Histidine kinase
JPH11253178A (ja) Ａｂｃ輸送体
EP0915161A2 (en) DnaG DNA primase of Streptococcus pneumoniae
EP1038962A1 (en) Peptidoglycan biosynthetic gene murF from Streptococcus pneumoniae

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued